Works by Munder, Markus

Results: 51
    1
    2
    3
    4
    5

    Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy.

    Published in:
    Advances in Therapy, 2021, v. 38, n. 2, p. 1328, doi. 10.1007/s12325-020-01601-w
    By:
    • Chari, Ajai;
    • Munder, Markus;
    • Weisel, Katja;
    • Jenner, Matthew;
    • Bygrave, Ceri;
    • Petrucci, Maria Teresa;
    • Boccadoro, Mario;
    • Cavo, Michele;
    • van de Donk, Niels W. C. J.;
    • Turgut, Mehmet;
    • Demirkan, Fatih;
    • Karadogan, Ihsan;
    • Libby, Edward;
    • Kleiman, Robert;
    • Kuppens, Steven;
    • Bandekar, Rajesh;
    • Neff, Tobias;
    • Heuck, Christoph;
    • Qi, Ming;
    • Clemens, Pamela L.
    Publication type:
    Article
    6
    7

    Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00772-9
    By:
    • Mai, Elias K.;
    • Huhn, Stefanie;
    • Miah, Kaya;
    • Poos, Alexandra M.;
    • Scheid, Christof;
    • Weisel, Katja C.;
    • Bertsch, Uta;
    • Munder, Markus;
    • Berlanga, Oscar;
    • Hose, Dirk;
    • Seckinger, Anja;
    • Jauch, Anna;
    • Blau, Igor W.;
    • Hänel, Mathias;
    • Salwender, Hans J.;
    • Benner, Axel;
    • Raab, Marc S.;
    • Goldschmidt, Hartmut;
    • Weinhold, Niels
    Publication type:
    Article
    8

    Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00390-3
    By:
    • Baertsch, Marc-Andrea;
    • Mai, Elias K.;
    • Hielscher, Thomas;
    • Bertsch, Uta;
    • Salwender, Hans J.;
    • Munder, Markus;
    • Fuhrmann, Stephan;
    • Dührsen, Ulrich;
    • Brossart, Peter;
    • Neben, Kai;
    • Schlenzka, Jana;
    • Kunz, Christina;
    • Raab, Marc S.;
    • Hillengaß, Jens;
    • Jauch, Anna;
    • Seckinger, Anja;
    • Hose, Dirk;
    • Luntz, Steffen;
    • Sonneveld, Pieter;
    • Lokhorst, Henk
    Publication type:
    Article
    9
    10

    Macrophage: SHIP of Immunity.

    Published in:
    2014
    By:
    • Mills, Charles D.;
    • Thomas, Anita C.;
    • Lenz, Laurel L.;
    • Munder, Markus;
    • Lugo-Villarino, Geanncarlo
    Publication type:
    Opinion
    11
    12
    13
    14
    15
    16

    Arginase Activity in the Blood of Patients with Visceral Leishmaniasis and HIV Infection.

    Published in:
    PLoS Neglected Tropical Diseases, 2013, v. 7, n. 1, p. 1, doi. 10.1371/journal.pntd.0001977
    By:
    • Takele, Yegnasew;
    • Abebe, Tamrat;
    • Weldegebreal, Teklu;
    • Hailu, Asrat;
    • Hailu, Workagegnehu;
    • Hurissa, Zewdu;
    • Ali, Jemal;
    • Diro, Ermiyas;
    • Sisay, Yifru;
    • Cloke, Tom;
    • Modolell, Manuel;
    • Munder, Markus;
    • Tacchini-Cottier, Fabienne;
    • Müller, Ingrid;
    • Kropf, Pascale
    Publication type:
    Article
    17

    Arginase Activity in the Blood of Patients with Visceral Leishmaniasis and HIV Infection.

    Published in:
    PLoS Neglected Tropical Diseases, 2013, v. 7, n. 1, p. 1, doi. 10.1371/journal.pntd.0001977
    By:
    • Takele, Yegnasew;
    • Abebe, Tamrat;
    • Weldegebreal, Teklu;
    • Hailu, Asrat;
    • Hailu, Workagegnehu;
    • Hurissa, Zewdu;
    • Ali, Jemal;
    • Diro, Ermiyas;
    • Sisay, Yifru;
    • Cloke, Tom;
    • Modolell, Manuel;
    • Munder, Markus;
    • Tacchini-Cottier, Fabienne;
    • Müller, Ingrid;
    • Kropf, Pascale
    Publication type:
    Article
    18
    19
    20
    21
    22

    Monoclonal gammopathy of ocular significance (MGOS) – a short survey of corneal manifestations and treatment outcomes.

    Published in:
    Leukemia & Lymphoma, 2022, v. 63, n. 4, p. 984, doi. 10.1080/10428194.2021.2008385
    By:
    • Garderet, Laurent;
    • Al Hariri, Mohammad;
    • Wasielica-Poslednik, Joanna;
    • Munder, Markus;
    • Kormányos, Kitti;
    • Pena, Camila;
    • Gozzetti, Alessandro;
    • Zhou, Xiang;
    • Waszczuk-Gajda, Anna;
    • Rosinol, Laura;
    • Mikala, Gabor;
    • Krzystanski, Mateusz;
    • Lisch, Walter;
    • Vesole, David;
    • Szentmáry, Nóra;
    • Jurczyszyn, Artur
    Publication type:
    Article
    23
    24
    25

    Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial.

    Published in:
    Hematology, 2024, v. 29, n. 1, p. 1, doi. 10.1080/16078454.2024.2320006
    By:
    • Salwender, Hans;
    • Weinhold, Niels;
    • Benner, Axel;
    • Miah, Kaya;
    • Merz, Maximilian;
    • Haenel, Mathias;
    • Jehn, Christian;
    • Mai, Elias;
    • Menis, Ekaterina;
    • Blau, Igor;
    • Scheid, Christof;
    • Hose, Dirk;
    • Seckinger, Anja;
    • Luntz, Steffen;
    • Besemer, Britta;
    • Munder, Markus;
    • Brossart, Peter;
    • Glass, Bertram;
    • Lindemann, Hans-Walter;
    • Weisel, Katja
    Publication type:
    Article
    26
    27
    28
    29
    30

    SAMHD1 in cancer: curse or cure?

    Published in:
    Journal of Molecular Medicine, 2022, v. 100, n. 3, p. 351, doi. 10.1007/s00109-021-02131-w
    By:
    • Schott, Kerstin;
    • Majer, Catharina;
    • Bulashevska, Alla;
    • Childs, Liam;
    • Schmidt, Mirko H. H.;
    • Rajalingam, Krishnaraj;
    • Munder, Markus;
    • König, Renate
    Publication type:
    Article
    31
    32

    Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial.

    Published in:
    Cancers, 2021, v. 13, n. 19, p. 4856, doi. 10.3390/cancers13194856
    By:
    • Klein, Eva-Maria;
    • Tichy, Diana;
    • Salwender, Hans J.;
    • Mai, Elias K.;
    • Duerig, Jan;
    • Weisel, Katja C.;
    • Benner, Axel;
    • Bertsch, Uta;
    • Akhavanpoor, Mabast;
    • Besemer, Britta;
    • Munder, Markus;
    • Lindemann, Hans-Walter;
    • Hose, Dirk;
    • Seckinger, Anja;
    • Luntz, Steffen;
    • Jauch, Anna;
    • Elmaagacli, Ahmet;
    • Fuhrmann, Stephan;
    • Brossart, Peter;
    • Goerner, Martin
    Publication type:
    Article
    33

    Health‐related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 561, doi. 10.1111/bjh.17321
    By:
    • Hungria, Vania;
    • Beksac, Meral;
    • Weisel, Katja C.;
    • Nooka, Ajay K.;
    • Masszi, Tamas;
    • Spicka, Ivan;
    • Munder, Markus;
    • Mateos, María‐Victoria;
    • Mark, Tomer M.;
    • Qi, Ming;
    • Qin, Xiang;
    • Fastenau, John;
    • Spencer, Andrew;
    • Sonneveld, Pieter;
    • Garvin, Wendy;
    • Renaud, Thomas;
    • Gries, Katharine S.
    Publication type:
    Article
    34

    Reconstitution of T Cell Proliferation under Arginine Limitation: Activated Human T Cells Take Up Citrulline via L-Type Amino Acid Transporter 1 and Use It to Regenerate Arginine after Induction of Argininosuccinate Synthase Expression.

    Published in:
    Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.00864
    By:
    • Werner, Anke;
    • Koschke, Miriam;
    • Leuchtner, Nadine;
    • Luckner-Minden, Claudia;
    • Habermeier, Alice;
    • Rupp, Johanna;
    • Heinrich, Christin;
    • Conradi, Roland;
    • Closs, Ellen I.;
    • Munder, Markus
    Publication type:
    Article
    35

    Visceral leishmaniasis Patients Display altered composition and Maturity of neutrophils as well as impaired neutrophil effector Functions.

    Published in:
    Frontiers in Immunology, 2016, v. 7, p. 1, doi. 10.3389/fimmu.2016.00517
    By:
    • Yizengaw, Endalew;
    • Getahun, Mulusew;
    • Tajebe, Fitsumbrhan;
    • Cervera, Edward Cruz;
    • Adem, Emebet;
    • Mesfin, Getnet;
    • Hailu, Asrat;
    • Van der Auwera, Gert;
    • Yardley, Vanessa;
    • Lemma, Mulualem;
    • Skhedy, Ziv;
    • Diro, Ermias;
    • Yeshanew, Arega;
    • Melkamu, Roma;
    • Mengesha, Bewketu;
    • Modolell, Manuel;
    • Munder, Markus;
    • Müller, Ingrid;
    • Takele, Yegnasew;
    • Kropf, Pascale
    Publication type:
    Article
    36
    37

    Characterization of Neutrophil Subsets in Healthy Human Pregnancies.

    Published in:
    PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0085696
    By:
    • Ssemaganda, Aloysius;
    • Kindinger, Lindsay;
    • Bergin, Philip;
    • Nielsen, Leslie;
    • Mpendo, Juliet;
    • Ssetaala, Ali;
    • Kiwanuka, Noah;
    • Munder, Markus;
    • Teoh, Tiong Ghee;
    • Kropf, Pascale;
    • Müller, Ingrid
    Publication type:
    Article
    38
    39

    Cytotoxicity of Tumor Antigen Specific Human T Cells Is Unimpaired by Arginine Depletion

    Published in:
    PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0063521
    By:
    • Munder, Markus;
    • Engelhardt, Melanie;
    • Knies, Diana;
    • Medenhoff, Sergej;
    • Wabnitz, Guido;
    • Luckner-Minden, Claudia;
    • Feldmeyer, Nadja;
    • Voss, Ralf-Holger;
    • Kropf, Pascale;
    • Müller, Ingrid;
    • Conradi, Roland;
    • Samstag, Yvonne;
    • Theobald, Matthias;
    • Ho, Anthony D.;
    • Goldschmidt, Hartmut;
    • Hundemer, Michael
    Publication type:
    Article
    40
    41
    42

    P-177: Predictive factors for severe infections and early death during novel agent-based induction therapy in newly diagnosed, transplant-eligible myeloma: a multicohort analysis from phase III trials.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S133, doi. 10.1016/S2152-2650(21)02304-1
    By:
    • Mai, Elias;
    • Hielscher, Thomas;
    • Bertsch, Uta;
    • Salwender, Hans J.;
    • Munder, Markus;
    • Brossart, Peter;
    • Blau, Igor W.;
    • Raab, Marc;
    • Duerig, Jan;
    • Giesen, Nicola;
    • Besemer, Britta;
    • Fenk, Roland;
    • Wattad, Mohammed;
    • Haenel, Mathias;
    • von Metzler, Ivana;
    • Graeven, Ullrich;
    • Scheid, Christoph;
    • Weisel, Katja;
    • Goldschmidt, Hartmut
    Publication type:
    Article
    43

    Normalization of serum free light chains during therapy in the MM5 trial predicts prolonged progression free survival and overall survival.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e208, doi. 10.1016/j.clml.2019.09.346
    By:
    • Haas, Eva-Maria;
    • Salwender, Hans J.;
    • Mai, Elias K.;
    • Dürig, Jan;
    • Weisel, Katja;
    • Tichy, Diana;
    • Benner, Axel;
    • Kunz, Christina;
    • Hielscher, Thomas;
    • Bertsch, Uta;
    • Besemer, Britta;
    • Merz, Maximilian;
    • Munder, Markus;
    • Lindemann, Hans-Walter;
    • Hügle-Dörr, Barbara;
    • Giessen, Nicola;
    • Hose, Dirk;
    • Seckinger, Anja;
    • Huhn, Stefanie;
    • Luntz, Steffen
    Publication type:
    Article
    44

    Comparison of bortezomib versus lenalidomide maintenance therapy in newly-diagnosed, transplant-eligible multiple myeloma: Results from the phase III GMMG-HD4 and -MM5 trials.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e43, doi. 10.1016/j.clml.2019.09.065
    By:
    • Mai, Elias K.;
    • Baertsch, Marc-A.;
    • Hielscher, Thomas;
    • Bertsch, Uta;
    • Schlenzka, Jana;
    • Salwender, Hans J.;
    • Munder, Markus;
    • Fuhrmann, Stephan;
    • Duehrsen, Ulrich;
    • Brossart, Peter;
    • Neben, Kai;
    • Raab, Marc S.;
    • Jauch, Anna;
    • Seckinger, Anja;
    • Hose, Dirk;
    • Luntz, Steffen;
    • Sonneveld, Pieter;
    • Lokhorst, Henk;
    • Martin, Hans;
    • Lindemann, Hans-Walter
    Publication type:
    Article
    45
    46

    Disease severity in patients with visceral leishmaniasis is not altered by co-infection with intestinal parasites.

    Published in:
    PLoS Neglected Tropical Diseases, 2017, v. 11, n. 7, p. 1, doi. 10.1371/journal.pntd.0005727
    By:
    • Tajebe, Fitsumbrhan;
    • Getahun, Mulusew;
    • Adem, Emebet;
    • Hailu, Asrat;
    • Lemma, Mulualem;
    • Fikre, Helina;
    • Raynes, John;
    • Tamiru, Aschalew;
    • Mulugeta, Zemenay;
    • Diro, Ermias;
    • Toulza, Frederic;
    • Shkedy, Ziv;
    • Ayele, Tadesse;
    • Modolell, Manuel;
    • Munder, Markus;
    • Müller, Ingrid;
    • Takele, Yegnasew;
    • Kropf, Pascale
    Publication type:
    Article
    47

    Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk.

    Published in:
    Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13045-020-00948-5
    By:
    • Weisel, Katja;
    • Spencer, Andrew;
    • Lentzsch, Suzanne;
    • Avet-Loiseau, Hervé;
    • Mark, Tomer M.;
    • Spicka, Ivan;
    • Masszi, Tamas;
    • Lauri, Birgitta;
    • Levin, Mark-David;
    • Bosi, Alberto;
    • Hungria, Vania;
    • Cavo, Michele;
    • Lee, Je-Jung;
    • Nooka, Ajay;
    • Quach, Hang;
    • Munder, Markus;
    • Lee, Cindy;
    • Barreto, Wolney;
    • Corradini, Paolo;
    • Min, Chang-Ki
    Publication type:
    Article
    48
    49
    50

    Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy.

    Published in:
    European Journal of Immunology, 2007, v. 37, n. 4, p. 935, doi. 10.1002/eji.200636542
    By:
    • Kropf, Pascale;
    • Baud, David;
    • Marshall, Sara E.;
    • Munder, Markus;
    • Mosley, Angelina;
    • Fuentes, José M.;
    • Bangham, Charles R. M.;
    • Taylor, Graham P.;
    • Herath, Shanti;
    • Choi, Beak-San;
    • Soler, Germán;
    • Teoh, Tg;
    • Modolell, Manuel;
    • Müller, Ingrid
    Publication type:
    Article